InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（8 笔）
内部人交易记录
其他已披露买入
1
已披露卖出
8
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Atlas Venture Fund XI, L.P.. Director active across 6 companies, notably Day One Biopharmaceuticals, Inc.. Aggregated, 18 disclosures have been published. Breakdown: 1 buy · 8 sells. Total volume traded: €11.7m. History available since 13 July 2021. The latest transaction was filed on 1 November 2024 (J). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Atlas Venture Fund XI, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
2,886,293 股Common StockSEC:0000950170-25-017030:0
515,688 股0Common StockSEC:0001415889-24-026125:0
136,312 股@ US$23.5929.8% 占其流量Common StockSEC:0001415889-24-005777:0
149,337 股@ US$22.4431.0% 占其流量Common StockSEC:0001415889-24-005124:0
175,793 股@ US$23.8839.2% 占其流量Common StockSEC:0001415889-24-004467:0
733 股@ US$0.6411.7% 占其流量Common StockSEC:0001209191-24-003031:0
1,566 股@ US$0.8733.4% 占其流量Common StockSEC:0001209191-24-001655:0
569 股@ US$0.8712.1% 占其流量Common StockSEC:0001209191-24-001655:1
1,540 股@ US$0.8331.3% 占其流量Common StockSEC:0001209191-24-001655:2
560 股@ US$0.8311.4% 占其流量Common StockSEC:0001209191-24-001655:3
600,854 股0Common StockSEC:0001209191-22-061242:0
600,854 股0Common StockSEC:0001209191-22-050928:0
6,472,374 股Common StockSEC:0001209191-22-050535:0
125,000 股@ US$16.00100.0% 占其流量Common StockSEC:0001209191-21-069644:0
标准退出：2021年6月28日 (T+90)
801,138 股0Common StockSEC:0001209191-21-067018:0
1,372,998 股Common StockSEC:0001104659-21-130026:0
814,013 股0Common StockSEC:0001209191-21-046784:0
7,761,380 股Common StockSEC:0001209191-21-037402:0
18 条申报中的 18 条
About Atlas Venture Fund XI, L.P.
Atlas Venture Fund XI, L.P. is a declarant with 18 filings in total, linked to Xilio Therapeutics, Inc., Dyne Therapeutics, Inc., Day One Biopharmaceuticals, Inc., Third Harmonic Bio, Inc., Sionna Therapeutics, Inc. and Ikena Oncology, Inc. Over the sampled recent filings, from 2021-06-02 to 2025-02-10, the amounts shown are EUR 1705960 in purchases and EUR 9986276 in sales, with Cession as the modal transaction nature.
